Cargando…
Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis
Inflammatory responses to the novel coronavirus SARS-CoV-2, which causes COVID-19, range from asymptomatic to severe. Here we present a follow-up analysis of a longitudinal study characterizing COVID-19 immune responses from a father and son with distinctly different clinical courses. The father req...
Autores principales: | Hausburg, Melissa A., Banton, Kaysie L., Roshon, Michael, Bar-Or, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788102/ https://www.ncbi.nlm.nih.gov/pubmed/33437888 http://dx.doi.org/10.1016/j.heliyon.2020.e05877 |
Ejemplares similares
-
C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe?
por: Hausburg, Melissa A., et al.
Publicado: (2022) -
AMP5A modulates Toll-like receptors 7 and 8 single-stranded RNA immune responses in PMA-differentiated THP-1 and PBMC
por: Thomas, Gregory, et al.
Publicado: (2022) -
The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
por: Rael, Leonard T., et al.
Publicado: (2018) -
LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC
por: Thomas, Gregory, et al.
Publicado: (2020) -
The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis
por: Thomas, Gregory, et al.
Publicado: (2020)